news

한어Русский языкEnglishFrançaisIndonesianSanskrit日本語DeutschPortuguêsΕλληνικάespañolItalianoSuomalainenLatina

china news service, september 14. according to the united nations website, on september 13 local time, the world health organization approved the use of monkeypox vaccine for the first time, and said that this move will help millions of people at risk in africa to get vaccines in a timely and greater manner.

according to reports, the "modified vaccinia virus ankara bavarian nordic strain vaccine" produced by the danish pharmaceutical company bavarian nordic obtained pre-certification from the world health organization on the 13th local time and was approved in europe and the united states for use by adults.

who director-general tedros adhanom ghebreyesus said the prequalification of the vaccine was an important step in africa and in the future fight against monkeypox virus, which has infected more than 20,000 people in africa in the recent resurgence in 2024.

according to reports, monkeypox is a zoonosis caused by infection with the monkeypox virus. common clinical symptoms include rash, fever, swollen lymph nodes, headache, muscle aches, etc. in most cases, the symptoms will disappear on their own within a few weeks, but severe cases may cause complications or even death.

monkeypox virus can be transmitted through close contact between people, such as skin contact, close conversation or breathing with monkeypox patients. people can also be infected through contact with exudates or blood from infected animal lesions, or by being bitten or scratched by them, or by contact with objects contaminated with the virus.